A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects

BACKGROUND: Teduglutide, a recombinant analog of human glucagon-like peptide (GLP)-2, is a novel therapy recently approved for the treatment of adult patients with short bowel syndrome who are dependent on parenteral support. Previous studies assessing the effect of GLP-2 on gastric emptying in huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Berg, Jolene Kay, Kim, Eric H, Li, Benjamin, Joelsson, Bo, Youssef, Nader N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928318/
https://www.ncbi.nlm.nih.gov/pubmed/24517114
http://dx.doi.org/10.1186/1471-230X-14-25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928318/
https://www.ncbi.nlm.nih.gov/pubmed/24517114
http://dx.doi.org/10.1186/1471-230X-14-25

Ejemplares similares